| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1039548778 |
| P356 | DOI | 10.1007/S11926-010-0154-6 |
| P698 | PubMed publication ID | 21161617 |
| P2093 | author name string | N Lawrence Edwards | |
| P2860 | cites work | EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) | Q24675089 |
| EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) | Q24675150 | ||
| Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout | Q24675215 | ||
| Relation between adverse events associated with allopurinol and renal function in patients with gout | Q28353668 | ||
| Serum urate levels and gout flares: analysis from managed care data | Q31036297 | ||
| How well have diagnostic tests and therapies for gout been evaluated? | Q33742074 | ||
| How is gout managed in primary care? A review of current practice and proposed guidelines | Q33884300 | ||
| Update on gout: new therapeutic strategies and options | Q34090789 | ||
| Identification of urate crystals in gouty synovial fluid | Q34539768 | ||
| Febuxostat compared with allopurinol in patients with hyperuricemia and gout | Q34563183 | ||
| Sex differences in gout epidemiology: evaluation and treatment | Q35637966 | ||
| Quality of care indicators for gout management | Q35691678 | ||
| Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations | Q36013873 | ||
| Quality of care for gout in the US needs improvement | Q36749515 | ||
| Why is gout so poorly managed? | Q36946394 | ||
| Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout? | Q36956486 | ||
| Quality of care in gout: from measurement to improvement. | Q37005146 | ||
| Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). | Q40425414 | ||
| A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy | Q40504910 | ||
| Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency | Q40830127 | ||
| Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? | Q43571099 | ||
| Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. | Q43998228 | ||
| Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. | Q45332069 | ||
| Treatment-failure gout: a moving target | Q46401877 | ||
| Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level | Q46867932 | ||
| Treatment of chronic gout in patients with renal function impairment: an open, randomized, actively controlled study | Q57076803 | ||
| Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts | Q73236145 | ||
| The optimal use of allopurinol: an audit of allopurinol use in South Auckland | Q73274086 | ||
| Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout | Q79750900 | ||
| Gout medication treatment patterns and adherence to standards of care from a managed care perspective | Q79887308 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 154-159 | |
| P577 | publication date | 2011-04-01 | |
| P1433 | published in | Current Rheumatology Reports | Q23930052 |
| P1476 | title | Quality of care in patients with gout: why is management suboptimal and what can be done about it? | |
| P478 | volume | 13 |
| Q90705364 | A Case Report of Immunosuppressant Medication‒Associated Polyarticular Tophaceous Gout Successfully Treated Using the Polyethylene Glycol‒Conjugated Uricase Enzyme Pegloticase |
| Q37191351 | A Pharmacist-Staffed, Virtual Gout Management Clinic for Achieving Target Serum Uric Acid Levels: A Randomized Clinical Trial |
| Q35746133 | Adherence to the 2012 American College of Rheumatology (ACR) Guidelines for Management of Gout: A Survey of Brazilian Rheumatologists |
| Q40491609 | Computational Lexical Analysis of the Language Commonly Used to Describe Gout |
| Q37516253 | Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study |
| Q57245340 | Goals of gout treatment: a patient perspective |
| Q90317380 | Gout |
| Q52534066 | Gout and Metabolic Syndrome: a Tangled Web. |
| Q30238939 | Gout treatment: survey of Brazilian rheumatology residents. |
| Q88409004 | Key barriers to gout care: a systematic review and thematic synthesis of qualitative studies |
| Q92638674 | Patterns of health care utilization of gout patients in Hawai'i-high rates of emergency department utilization as compared to rheumatoid arthritis |
| Q47104100 | Pegloticase in gout treatment - safety issues, latest evidence and clinical considerations. |
| Q50111167 | Pilot study of a multidisciplinary gout patient education and monitoring program |
| Q34415029 | Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout |
| Q87100464 | Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China |
| Q39741682 | Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States |
| Q39207801 | Recent advances in understanding and managing gout |
| Q37971345 | The patient's experience of gout: new insights to optimize management |
| Q39450570 | Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada From 2000 to 2011. |
| Q87749268 | [Diagnosis and management of gout in Austria. Survey of current practice considering the EULAR recommendations] |
Search more.